An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Illinois Legislature Passes Hearing Care Plan Transparency
The Illinois General Assembly has passed Senate Bill 2838 (SB 2838), a measure designed to increase transparency, strengthen consumer protections, and improve fairness in hearing…
Medicaid Work Requirements Rule Could Affect Access to Hearing Healthcare
The Centers for Medicare and Medicaid Services (CMS) recently issued an Interim Final Rule implementing Medicaid work requirements for certain adult beneficiaries beginning in 2027….
Sleep in U.S. Adults
Previously, we reported on sleep routines and tiredness in children. You may now be wondering how well adults sleep. If so, a recent report by…


